BlackRock’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $24.5M | Sell |
|
|||||
|
2025
Q2 | $31.2M | Sell |
|
|||||
|
2025
Q1 | $26.7M | Sell |
|
|||||
|
2024
Q4 | $30.4M | Buy |
|
|||||
|
2024
Q3 | $30.1M | Sell |
|
|||||
|
2024
Q2 | $30.2M | Sell |
|
|||||
|
2024
Q1 | $37.3M | Sell |
|
|||||
|
2023
Q4 | $28.8M | Buy |
|
|||||
|
2023
Q3 | $24.6M | Buy |
|
|||||
|
2023
Q2 | $28.8M | Sell |
|
|||||
|
2023
Q1 | $26.9M | Buy |
|
|||||
|
2022
Q4 | $38.6M | Buy |
|
|||||
|
2022
Q3 | $44.8M | Buy |
|
|||||
|
2022
Q2 | $52.6M | Buy |
|
|||||
|
2022
Q1 | $47.8M | Buy |
|
|||||
|
2021
Q4 | $51.7M | Buy |
|
|||||
|
2021
Q3 | $145M | Buy |
|
|||||
|
2021
Q2 | $75M | Buy |
|
|||||
|
2021
Q1 | $66.4M | Sell |
|
|||||
|
2020
Q4 | $55M | Buy |
|